Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/27/25 19:22 | 1/23/25 | ARWR | Health | Drug | Pharmaceutical Preparations | Olukotun Adeoye Y | CA | D | 2 | S | -77 | 20.25 | 0 | -4 | 37 | D | ||||||||||||||||
1/7/25 21:28 | 1/6/25 | ARWR | Health | Drug | Pharmaceutical Preparations | Hamilton James C | CA | O | Chief Di | 1 | S | -649 | 19.82 | 0 | -33 | 272 | D | |||||||||||||||
1/7/25 21:28 | 1/6/25 | ARWR | Health | Drug | Pharmaceutical Preparations | O'Brien Patrick | CA | O | COO,GC | 1 | S.m | -736 | 19.80 | 0 | -37 | 527 | D | |||||||||||||||
1/7/25 21:27 | 1/6/25 | ARWR | Health | Drug | Pharmaceutical Preparations | Myszkowski Kenneth Allen | CA | O | CFO | 1 | S.m | -893 | 19.77 | 0 | -45 | 455 | D | |||||||||||||||
1/6/25 18:07 | 1/2/25 | ARWR | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | 3 | S | -1,033 | 20.34 | 0 | -51 | 3,788 | D | |||||||||||||||
12/18/24 18:19 | 12/16/24 | ARWR | Health | Drug | Pharmaceutical Preparations | Waddill William D. | CA | D | 1 | S.m | -165 | 21.97 | 0 | -7 | 40 | D | ||||||||||||||||
12/18/24 18:18 | 12/16/24 | ARWR | Health | Drug | Pharmaceutical Preparations | Given Douglas B | CA | D | 1 | S.m | -122 | 21.91 | 0 | -6 | 124 | D | ||||||||||||||||
12/18/24 18:15 | 12/16/24 | ARWR | Health | Drug | Pharmaceutical Preparations | Vakiener Victoria | CA | D | 1 | S | -197 | 21.91 | 0 | -9 | 21 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |